Skip to content

Machine Vision Based MDS-UPDRS III Machine Rating

Machine Vision Based Machine Rating of MDS-UPDRS III

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05906719
Enrollment
1679
Registered
2023-06-18
Start date
2023-03-01
Completion date
2025-12-31
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Machine Learning, Parkinsonian Disorders

Brief summary

The Movement Disorders Society (MDS) Unified Parkinson's Disease Rating Scale (UPDRS) Part III (MDS-UPDRS III) is the primary assessment method for motor symptoms in Parkinson's disease patients. Currently, movement disorder specialists conduct semi-quantitative scoring, which entails limitations such as subjectivity, weak sensitivity, and a limited number of professional physicians. This study, based on machine vision, establishes gold standard labels according to expert scoring. By using machine learning, we develop a machine rating model and compare the model's performance with gold standard rating and general clinical rating to investigate the accuracy of machine vision-based MDS-UPDRS III machine rating.

Interventions

Patients' performance of MDS-UPDRS III will be recorded.

Sponsors

Ruijin Hospital
Lead SponsorOTHER
Second Affiliated Hospital of Soochow University
CollaboratorOTHER
Beijing Hospital
CollaboratorOTHER_GOV
Beijing Tiantan Hospital
CollaboratorOTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
CollaboratorOTHER
Fujian Medical University Union Hospital
CollaboratorOTHER
Guangdong Provincial People's Hospital
CollaboratorOTHER
West China Hospital
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Meeting the diagnostic criteria for Parkinsonism established by the International Movement Disorder Society: having bradykinesia, and meeting at least one of the two criteria for resting tremor or muscle rigidity * 20 to 80 years old * Good compliance, voluntarily joining the study, and able to sign an informed consent form or have it signed by a legal representative

Exclusion criteria

* Significant cognitive impairment (MMSE ≤ 23) * Unable to sign written informed consent or unable to complete the trial due to other reasons * Other situations in which the researcher deems the participant unsuitable for this study * Participation in other clinical trials

Design outcomes

Primary

MeasureTime frameDescription
Item-level: MAE1 dayAt the item level, mean absolute error (MAE) between paired AI scores and consensus reference scores, calculated as the average absolute difference across items. Lower values indicate closer agreement.
Item-level: P(|Δ|≥2)1 dayAt the item level, the proportion of paired AI and consensus reference scores with an absolute difference of 2 or more points. Lower values indicate fewer large item-level scoring disagreements.
Score-level: ICC1 dayIntraclass correlation coefficient (ICC) between AI-derived scores and consensus reference scores, calculated separately for each of the four subdomain scores and the total score. Higher ICC values indicate greater agreement.
Score-level: SEM1 dayStandard error of measurement (SEM) for AI-derived scores relative to consensus reference scores, calculated separately for each of the four subdomain scores and the total score. SEM quantifies measurement error in the units of the corresponding score, with lower values indicating greater measurement precision.
Score-level: SDC1 daySmallest detectable change (SDC), derived from the measurement error and calculated separately for each of the four subdomain scores and the total score. SDC represents the minimum score change required to exceed expected measurement error. Lower values indicate greater measurement precision.

Secondary

MeasureTime frameDescription
Item-level: Within-one agreement (ACC1; P(|Δ| ≤ 1))1 dayAt the item level, ACC1 is defined as the proportion of paired AI and consensus reference scores with an absolute difference of no more than 1 point, i.e., P(\|Δ\| ≤ 1). Higher values indicate closer item-level agreement.
Item-level: Exact-error proportions [P(|Δ| = k)]1 dayAt the item level, exact-error proportions, P(\|Δ\| = k), represent the proportions of paired AI and consensus reference scores with each exact absolute error magnitude k. In particular, P(\|Δ\| = 0) corresponds to exact-match accuracy (ACC), defined as the proportion of items for which the AI score exactly matches the consensus reference score. The remaining values of k characterize the distribution of item-level scoring errors.
Item-level: Per-class exact recall1 dayAt the item level, for each consensus reference score class, the proportion of items for which the AI score exactly matches the consensus reference score among all items belonging to that reference class. Higher values indicate better class-specific exact agreement.
Item-level: Confusion matrix1 dayAt the item level, a cross-tabulation of AI scores against consensus reference scores, showing the number of paired ratings for each combination of reference and AI score categories. Rows represent consensus reference scores and columns represent AI scores.
Item-level: Row-normalised confusion matrix1 dayAt the item level, the confusion matrix normalised within each consensus reference score row so that each row sums to 1, showing the distribution of AI scores conditional on each reference score class.
Score-level: Limits of agreement1 dayBland-Altman limits of agreement between AI-derived scores and consensus reference scores, calculated separately for each of the four subdomain scores and the total score. The limits characterize the range within which most paired differences between AI and reference scores are expected to fall.
Score-level: MAE1 dayMean absolute error (MAE) between AI-derived scores and consensus reference scores, calculated separately for each of the four subdomain scores and the total score as the average absolute difference between paired scores. Lower values indicate smaller scoring errors.
Score-level: RMSE1 dayRoot mean square error (RMSE) between AI-derived scores and consensus reference scores, calculated separately for each of the four subdomain scores and the total score. RMSE gives greater weight to larger scoring errors, with lower values indicating closer agreement.
Score-level: Spearman correlation1 daySpearman rank correlation between AI-derived scores and consensus reference scores, calculated separately for each of the four subdomain scores and the total score. Higher values indicate a stronger monotonic association between AI-derived and reference scores.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026